Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The growth was fueled by its efficacy in treating type 2 diabetes, heart failure and chronic kidney disease (CKD)
Xie F, Xiong F, Yang B, Yan Z, Shen Y, Qin H, et al
Tesamorelin Tesamorelin is an FDA-approved GHRH analogue originally developed for HIV-associated lipodystrophy, but it has gained traction in the anti-aging and body recomposition space for its potent ability to reduce visceral adipose tissue (VAT)
Unlike the others, it is a dual agonist , targeting both GLP-1 and GIP receptors
US$ 23.05
US$ 28.64
US$ 21.72
